» Articles » PMID: 34694684

Virus-Mimicking Cell Membrane-Coated Nanoparticles for Cytosolic Delivery of MRNA

Overview
Specialty Chemistry
Date 2021 Oct 25
PMID 34694684
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Effective endosomal escape after cellular uptake represents a major challenge in the field of nanodelivery, as the majority of drug payloads must localize to subcellular compartments other than the endosomes in order to exert activity. In nature, viruses can readily deliver their genetic material to the cytosol of host cells by triggering membrane fusion after endocytosis. For the influenza A virus, the hemagglutinin (HA) protein found on its surface fuses the viral envelope with the surrounding membrane at endosomal pH values. Biomimetic nanoparticles capable of endosomal escape were fabricated using a membrane coating derived from cells engineered to express HA on their surface. When evaluated in vitro, these virus-mimicking nanoparticles were able to deliver an mRNA payload to the cytosolic compartment of target cells, resulting in the successful expression of the encoded protein. When the mRNA-loaded nanoparticles were administered in vivo, protein expression levels were significantly increased in both local and systemic delivery scenarios. We therefore conclude that utilizing genetic engineering approaches to express viral fusion proteins on the surface of cell membrane-coated nanoparticles is a viable strategy for modulating the intracellular localization of encapsulated cargoes.

Citing Articles

Engineered neutrophil membrane-camouflaged nanocomplexes for targeted siRNA delivery against myocardial ischemia reperfusion injury.

Jiang Y, Jiang R, Xia Z, Guo M, Fu Y, Wang X J Nanobiotechnology. 2025; 23(1):134.

PMID: 39987112 PMC: 11847384. DOI: 10.1186/s12951-025-03172-w.


Developing mRNA Nanomedicines with Advanced Targeting Functions.

Wang J, Cai L, Li N, Luo Z, Ren H, Zhang B Nanomicro Lett. 2025; 17(1):155.

PMID: 39979495 PMC: 11842722. DOI: 10.1007/s40820-025-01665-9.


A DNA origami-based enzymatic cascade nanoreactor for chemodynamic cancer therapy and activation of antitumor immunity.

Jiao Y, Wang H, Wang H, Xie Y, Shang Y, Wu Y Sci Adv. 2025; 11(2):eadr9196.

PMID: 39772676 PMC: 11708878. DOI: 10.1126/sciadv.adr9196.


Engineered Macrophage Membrane-Coated S100A9-siRNA for Ameliorating Myocardial Ischemia-Reperfusion Injury.

Lu H, Wang J, Chen Z, Wang J, Jiang Y, Xia Z Adv Sci (Weinh). 2024; 11(41):e2403542.

PMID: 39264262 PMC: 11538685. DOI: 10.1002/advs.202403542.


Biomimetic Nucleic Acid Drug Delivery Systems for Relieving Tumor Immunosuppressive Microenvironment.

Yan W, Cao Y, Yin Q, Li Y Pharmaceutics. 2024; 16(8).

PMID: 39204373 PMC: 11360391. DOI: 10.3390/pharmaceutics16081028.


References
1.
Wu X, Choi C, Zhang C, Hao L, Mirkin C . Intracellular fate of spherical nucleic acid nanoparticle conjugates. J Am Chem Soc. 2014; 136(21):7726-33. PMC: 4046773. DOI: 10.1021/ja503010a. View

2.
Convertine A, Benoit D, Duvall C, Hoffman A, Stayton P . Development of a novel endosomolytic diblock copolymer for siRNA delivery. J Control Release. 2008; 133(3):221-9. PMC: 3110267. DOI: 10.1016/j.jconrel.2008.10.004. View

3.
Chang W, Yu C, Lin T, Wang P, Tsai Y . Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells. Biochem Biophys Res Commun. 2006; 341(2):614-9. DOI: 10.1016/j.bbrc.2005.12.216. View

4.
Zhang C, An T, Wang D, Wan G, Zhang M, Wang H . Stepwise pH-responsive nanoparticles containing charge-reversible pullulan-based shells and poly(β-amino ester)/poly(lactic-co-glycolic acid) cores as carriers of anticancer drugs for combination therapy on hepatocellular carcinoma. J Control Release. 2016; 226:193-204. DOI: 10.1016/j.jconrel.2016.02.030. View

5.
Wang S, Duan Y, Zhang Q, Komarla A, Gong H, Gao W . Drug Targeting Platelet Membrane-Coated Nanoparticles. Small Struct. 2021; 1(1). PMC: 8011559. DOI: 10.1002/sstr.202000018. View